[Dapagliflozin (type 1 diabetes mellitus) - Addendum to Commission A19-37]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003594
German
Original Title:
Dapagliflozin (Diabetes mellitus Typ 1) - Addendum zum Auftrag A19-37
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a19-79.html
Year Published:
2019
URL for published report:
https://www.iqwig.de/download/A19-79_Dapagliflozin_Addendum-zum-Auftrag-A19-37_V1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Diabetes Mellitus, Type 1
- Sodium-Glucose Transporter 2 Inhibitors
- Hypoglycemic Agents
Keywords
- Dapagliflozin
- Insulin
- Diabetes Mellitus - Type 1
- Benefit Assessment
- NCT02268214
- NCT02460978
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.